CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/education

education organization

University of Tennessee Health Science Center

US

OPENALEX: I160606119↗ROR: 0011qv509↗

People

Connected researchers

Ammaar H. AbidiORCID 0000-0003-1826-9377 James W. WhelessORCID 0000-0002-4735-3431 Karen DerefinkoORCID 0000-0001-8589-5330 Kristin HamreORCID 0000-0002-8302-3827 Megan K. MulliganORCID 0000-0003-4909-635X

Public evidence

3 connected articles

Influence of prenatal cannabinoid exposure on early development and beyond.2023 · Europe PMC A critical review of cannabis in medicine and dentistry: A look back and the path forward.2022 · Europe PMC Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy.2019 · PubMed Central Open Access

Registered research

Connected studies

A Phase 1/2 Study to Assess the Pharmacokinetics and Safety of Multiple Doses of Pharmaceutical Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Seizure Disordersnct02324673 Evaluating the Efficacy of Cannabidiol for Reducing Cigarette Usenct06218056

Matched by exact identifiers only. Profile data: OpenAlex.

University of Tennessee Health Science Center - Medical Cannabis Research Engine